Pacific Edge upbeat about latest move for new Cxbladder test

Pacific Edge upbeat about latest move for new Cxbladder test
Pacific Edge says Cxbladder Triage Plus delivers “significant performance improvements” compared to its existing tests. Image: Pacific Edge)
Rebecca Howard
Pacific Edge is upbeat about the draft gapfill or reimbursement rates for its new Cxbladder Triage Plus test from the US Centres for Medicare and Medicaid Services.Gapfill prices are proposed reimbursement rates for new or unpriced clinical diagnostic laboratory tests.The median price for Cxbladder Triage Plus is US$1,018 (NZ$1,708), according to the gapfill prices.When finalised, the US Centres for Medicare and Medicaid Services (CMS) price for Triage Plus sets the amount Pacific Edge will be reimbursed for all patients with Medicare and Medic...

More Markets

Vital board backs Tait takeover
Markets

Vital board backs Tait takeover

Vital’s board has unanimously recommended that shareholders and option holders accept a full takeover offer from Tait Communications, despite their view that it undervalues the company.In May, Vital shares rallied after it disclosed that Tait, a Christchurch-based critical commun...

Drury’s ASX stag, MetroGlass’s new owner, and more
Markets Small Cap Wrap

Drury’s ASX stag, MetroGlass’s new owner, and more

Rod Drury goes ‘pre-revenue’ again, plus small cap news from NZ.

Listed property firms welcome ‘Investment Boost'
Property

Listed property firms welcome ‘Investment Boost'

The tax policy could translate into millions in extra cash.

NZX down as property company gets key renewal
Markets Market Close

NZX down as property company gets key renewal

ASB Bank has extended the lease for its downtown Auckland site for another nine years.

Tom Raynel 03 Jul 2025